HansBiomed Statistics

Total Valuation

HansBiomed has a market cap or net worth of KRW 95.06 billion. The enterprise value is 121.06 billion.

Market Cap	95.06B
Enterprise Value	121.06B

Important Dates

The next estimated earnings date is Thursday, December 19, 2024.

Earnings Date	Dec 19, 2024
Ex-Dividend Date	n/a

Share Statistics

HansBiomed has 12.99 million shares outstanding. The number of shares has increased by 22.39% in one year.

Current Share Class	n/a
Shares Outstanding	12.99M
Shares Change (YoY)	+22.39%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	27.62%
Owned by Institutions (%)	0.79%
Float	6.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.14
PB Ratio	1.29
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 90.26, with an EV/FCF ratio of -148.87.

EV / Earnings	-12.75
EV / Sales	1.50
EV / EBITDA	90.26
EV / EBIT	n/a
EV / FCF	-148.87

Financial Position

The company has a current ratio of 1.10, with a Debt / Equity ratio of 0.45.

Current Ratio	1.10
Quick Ratio	0.45
Debt / Equity	0.45
Debt / EBITDA	11.25
Debt / FCF	-41.47
Interest Coverage	-1.00

Financial Efficiency

Return on equity (ROE) is -15.81% and return on invested capital (ROIC) is -1.40%.

Return on Equity (ROE)	-15.81%
Return on Assets (ROA)	-1.16%
Return on Capital (ROIC)	-1.40%
Revenue Per Employee	634.95M
Profits Per Employee	-74.75M
Employee Count	127
Asset Turnover	0.64
Inventory Turnover	1.12

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.02% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-52.02%
50-Day Moving Average	9,007.00
200-Day Moving Average	11,629.20
Relative Strength Index (RSI)	30.15
Average Volume (20 Days)	27,227

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HansBiomed had revenue of KRW 80.64 billion and -9.49 billion in losses. Loss per share was -752.85.

Revenue	80.64B
Gross Profit	49.75B
Operating Income	-2.33B
Pretax Income	-8.82B
Net Income	-9.49B
EBITDA	3.00B
EBIT	-2.33B
Loss Per Share	-752.85

Full Income Statement

Balance Sheet

The company has 8.02 billion in cash and 33.73 billion in debt, giving a net cash position of -25.70 billion or -1,979.07 per share.

Cash & Cash Equivalents	8.02B
Total Debt	33.73B
Net Cash	-25.70B
Net Cash Per Share	-1,979.07
Equity (Book Value)	74.14B
Book Value Per Share	5,686.06
Working Capital	4.58B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.56 billion and capital expenditures -2.37 billion, giving a free cash flow of -813.21 million.

Operating Cash Flow	1.56B
Capital Expenditures	-2.37B
Free Cash Flow	-813.21M
FCF Per Share	-62.62

Full Cash Flow Statement

Margins

Gross margin is 61.70%, with operating and profit margins of -2.89% and -11.77%.

Gross Margin	61.70%
Operating Margin	-2.89%
Pretax Margin	-10.94%
Profit Margin	-11.77%
EBITDA Margin	3.72%
EBIT Margin	-2.89%
FCF Margin	-1.01%

Dividends & Yields

HansBiomed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.39%
Shareholder Yield	-22.39%
Earnings Yield	-10.28%
FCF Yield	-0.86%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HansBiomed has an Altman Z-Score of 2.89. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.89
Piotroski F-Score	n/a